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Posterior reversible encephalopathy syndrome (PRES) is a neuro­
logical condition first described in 1996[1] and defined as reversible 
subcortical vasogenic brain oedema presenting with neurological 
symptoms[2] including encephalopathy, seizures, headaches and visual 
disturbances. The diagnosis is confirmed radiologically by decreased 
diffusivity of cortical and subcortical brain tissue of T2­weighted 
magnetic resonance imaging (MRI).[2,3] The two main hypotheses of 
the pathogenesis of PRES are related to factors influencing cerebral 
perfusion and endothelial dysfunction.[4]
Despite a growing number of studies describing PRES, the 
risk factors, symptomatology and pathophysiology are not well 
understood. Although PRES is well documented in the adult 
population, little is known about the disease process in children. A 
limited number of PRES diagnoses associated with renal disease in 
paediatric patients have been described in the literature to date, and 
all of these are case reports.[5­17]
The diagnosis of PRES is important because the prognosis is 
generally favourable[18] and these children should be offered intensive 
care even in low­resource settings, where misdiagnosis may mean 
that they would be considered poor candidates. The diagnosis is 
usually made on MRI when predisposing factors and symptoms 
are suggestive, but it may be more sensitively detected by an 
electroencephalogram showing focal non­convulsive seizures or 
status epilepticus.[18]
We postulate that as a disease entity PRES is not entirely 
separate from hypertensive encephalopathy and may represent a 
radiographically imaged and more severe presentation of the same 
disease process, now identifiable  because of the availability of MRI. 
We therefore reviewed the presentation, diagnosis and outcome 
of PRES in paediatric renal patients at Chris Hani Baragwanath 
Academic Hospital, Johannesburg, South Africa, and compared these 
with published case reports.
Methods
We retrospectively report on the records of five children with 
renal disease diagnosed with PRES at Chris Hani Baragwanath 
Academic Hospital between 1 January 2000 and 31 January 2017. 
Data pertaining to their demographics, underlying diagnosis, medical 
therapy, biochemi cal and haematological parameters, blood pressure, 
clinical presentation, radiological findings and outcome are detailed. 
This information is compared with all published articles on PRES 
in paediatric renal patients in the PubMed database. The search 
terms ‘posterior reversible (leuko)encephalopathy syndrome’ AND 
‘paediatric’, ‘pediatric’ OR ‘child’ AND ‘renal’ OR ‘kidney’ were used. 
Ethical permission was obtained from the Human Research Ethics 
Committee, University of the Witwatersrand, Johannesburg (ref. no. 
M1611153).
Setting
Chris Hani Baragwanath Academic Hospital is a tertiary institution 
in Soweto, Johannesburg, affiliated with the University of the 
Witwatersrand. The paediatric renal department sees ~1 500 patients 
per year, and admits ~30 patients per month.
Results
Case 1
An 11­year­old girl on peritoneal dialysis (PD) for chronic kidney 
disease (CKD) due to granulomatosis with polyangiitis developed 
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generalised tonic­clonic seizures, right­sided hemiplegia and cortical 
blindness. These symptoms deteriorated over 2 days, and she 
became non­responsive and required ventilatory support. Prior to 
onset of the above symptoms there had been worsening control 
of her blood pressure, which was 160/110 mmHg at its highest 
(50th centile 101/60 mmHg),[19] and worsening biochemical markers 
of renal function while on PD (blood urea level 10.6 mmol/L, 
serum creatinine 844 µmol/L, serum sodium 149 mmol/L). She had 
completed a course of empirical antibiotics for suspected bacterial 
peritonitis. Her chronic medications were prednisone (2 mg/kg), 
spironolactone, enalapril, folate, mycophenolate mofetil (MMF), oral 
potassium and phosphate replacement. She had received no recent 
blood transfusions, and her serum haemoglobin concentration was 
8.1 g/dL. A non­contrast computed tomography (CT) image of her 
brain showed an area of hypodensity in the right cortex. Cranial 
magnetic resonance imaging (cMRI) revealed multiple areas of T2/
flair hyperintensity involving white matter in the posterior parietal 
lobes, occipital lobes and cerebellar white matter (Fig. 1). A diagnosis 
of PRES was made, and she was ventilated, her blood pressure was 
treated, and her medication and PD continued. She became more 
responsive, and 10 days after the onset of the initial symptoms 
had made an almost complete neurological recovery. She was 
discharged with some residual right­hand weakness, and dysarthria 
on maintenance sodium valproate. She died within 6  months of 
discharge from complications of her renal failure.
Case 2
A 9­year­old boy known to have steroid­dependent minimal­change 
nephrotic syndrome and hypertension was admitted with intractable 
seizures requiring ventilation. On admission he had elevated blood 
pressure (150/100 mmHg, 50th centile 100/60 mmHg)[19] and normal 
renal function. His blood urea level was 1.5 mmol/L, serum creatinine 
40 µmol/L and serum sodium 141 mmol/L, while his haemoglobin 
concentration was normal at 13.3 g/dL. His chronic medications 
were prednisone (2 mg/kg), enalapril, spironolactone, perindopril, 
simvastatin and MMF. A non­contrast CT image of his brain revealed 
cerebral oedema, and cMRI revealed T2 hyperintensity in the 
frontal and parietal lobes as well as watershed infarcts. He improved 
rapidly with management of his blood pressure. On follow­up he 
had no residual neurological symptoms and no further seizures on 
maintenance sodium valproate.
Case 3
An 8­year­old girl on PD for CKD due to immune complex­mediated 
focal segmental glomerular sclerosis developed seizures and cortical 
blindness while in the ward. Her blood pressure was elevated 
(125/95 mmHg, 50th centile 96/57 mmHg)[19] and she had worsening 
renal function with a blood urea level of 5 mmol/L, serum creatinine 
544 µmol/L and serum sodium 133 mmol/L. Her haemoglobin 
concentration was 10.1 g/dL, and she had not received any blood 
transfusion. She was managed on weaning doses of prednisone 
(1 mg/kg), MMF, 1­alpha vitamin D, calcium, folate, potassium, 
thiamine and ferrous oral supplementation, erythropoietin and 
omeprazole. cMRI revealed extensive white­matter disease with T2/
flair hyperintensities globally. Her symptoms resolved completely 
within a month of onset.
Case 4
A 10­year­old girl had newly diagnosed nephrotic syndrome with 
immune complex­mediated focal segmental glomerular sclerosis. 
Having been pulsed with methylprednisone and on prednisone 
(2  mg/kg), she developed transient visual loss and seizures and was 
brought to hospital. Her blood pressure was also elevated (144/99 
mmHg, 50th centile 99/59 mmHg)[19] and she had an elevated blood 
urea level of 8.6 mmol/L, serum creatinine 103 µmol/L and serum 
sodium 141 mmol/L. Her haemoglobin concentration was 10.6 g/
dL. Her medication included prednisone (2 mg/kg), antituberculosis 
treatment, spironolactone, amlodipine, doxazosin and simvastatin. 
cMRI was unavailable at the time, and CT imaging showed some 
hypodensities in the parietal and occipital lobes. Her visual loss 
resolved with blood pressure control, and she is now well.
Case 5
A 10­year­old girl on PD with end­stage renal disease secondary to 
HIV­associated nephropathy was admitted with a history of new­
onset focal seizures. On admission her blood pressure was elevated 
(168/130 mmHg, 50th centile 100/59 mmHg).[19] Her blood urea level 
was 11.2 mmol/L, serum creatinine 779 µmol/L and serum sodium 
135 mmol/L. Her haemoglobin concentration was 10.1 g/dL, She was 
on antiretroviral treatment, enalapril, amlodipine, metoprolol, folate, 
calcium carbonate, vitamin D, erythropoietin and prednisone (2 mg/
kg). CT imaging identified multifocal white­matter hypodensitites 
and a thinned cortex. cMRI T2/flair identified hyperintensities in 
the parietal and occipital lobes. She was started on sodium valproate, 
with good seizure control and no neurological deficit.
Review of the literature
We identified 12 published case reports or series describing 64 
children aged between birth and 14 years of age with renal disease 
who had been diagnosed with PRES.[5­17] Their mean age was 9.1 
years. There were 24 males, 24 females and 16 of unreported sex. 
The baseline diagnoses of all the reviewed patients (N=64) are shown 
in Fig. 2. Most reviewed patients (91%), and all the newly reported 
patients, had hypertension at the time of onset of symptoms. Thirty­
five of the 64 reviewed patients were on immunosuppressive drugs, 3 
were receiving haemodialysis and 5 PD, and 4 had undergone renal 
transplants.
Seizures were the presenting symptom in 91% of cases, an altered level 
of consciousness in 63%, headaches in 50% and visual disturbances in 
41% (Fig. 3). The radiological cMRI diagnosis mostly involved changes 
Fig. 1. Case 1. T2/flair magnetic resonance image showing multiple hyper­
intensities (arrows).
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in the occipital lobe (91%), but also in the parietal lobe (73%), frontal 
lobe (36%) and temporal lobe (39%) (Fig. 4). Complete recovery was 
reported in 87.5% of cases, residual epilepsy in 5% and recurrence of 
PRES in 5%; there was one report of other non­specified neurological 
sequelae, and one patient was lost to follow­up.
Discussion
The five newly reported cases are similar to those reviewed in the 
literature in terms of age at presentation (mean 9.6 years, literature 
review 9.5 years). There were equal numbers of female and male 
patients in the 64 reviewed children, but four of the five newly repor­
ted cases were female. Because of the limited cohort size it is difficult 
to comment on the significance of this finding, but it is in keeping 
with existing literature reporting that more females than males develop 
PRES.[5]
Four of the five reported cases had nephrotic syndrome­related 
diagnoses, while 48% of the reviewed cases were similarly afflicted 
(although this figure may be higher, as 19% of the reviewed cases 
were reported to be in end­stage renal disease without a specified 
underlying diagnosis). Three of the five reported cases were in end­
stage renal disease and undergoing renal replacement therapy, and 
only one patient had a normal estimated glomerular filtration rate. 
This represents a higher proportion of patients with advanced renal 
disease than that reflected in the literature. The development of PRES 
as a complication of PD or uraemic encephalopathy therefore does not 
fully explain the pathogenesis in all the cases.
Only one of the five reported cases and 11% of the reviewed cases 
had been diagnosed with systemic vasculitis at the time of PRES 
diagnosis. In keeping with the hypothesis that the pathogenesis of 
PRES is related to endothelial inflammation,[4] this would suggest that 
a process other than vasculitis caused the implicated inflammation in 
these cases.
Importantly, all the reported patients and 91% of the reviewed 
patients were hypertensive at the time of PRES diagnosis. Only one 
patient diagnosed with renovascular hypertension was diagnosed 
with PRES in the reviewed literature. All the reported patients 
were hypertensive on medication prior to symptom development. 
However, it is surprising that no patient with Takayasu’s arteritis or 
other renovascular hypertensive disease seen in our department has 
developed PRES. We postulate that PRES may be related to the rate of 
rise of blood pressure instead of the sustained levels of hypertension in 
these patients.
Although PRES associated with blood transfusion has been reported 
in the literature,[20] this was not observed in our patients. One of the 
five reported patients had a haemoglobin concentration <10 g/dL, 
and none had received blood transfusion prior to the development 
of symptoms. This was not universally reported on in the reviewed 
patients. All the reported patients were on prednisone at the time of 
onset of symptoms, and two were on other immunosuppressive therapy 
(MMF). All the reported patients had normal serum sodium levels.
The most common presenting symptom in the literature was seizures 
(91%), and all the reported patients presented with seizures. There are 
reports that PRES may be considered an epileptic disorder,[18] and that 
it could be monitored or predicted by electroencephalography, which 
would show either focal non­convulsive seizures or status epilepticus. 
However, three of the five reported patients were not treated with 
maintenance antiepileptic drugs and have not had recurrences of 
seizures. The need for maintenance antiepileptic medication should 
be reviewed, especially in this patient group, as they require multiple 
drugs for renal failure and the underlying disease.
The pattern of cMRI changes at PRES diagnosis reviewed in the 
literature showed a predominance of occipital and parietal changes, 
which is consistent with the reported cases in which this imaging 
modality was available. It also to some extent explains the frequency 
of visual disturbances present at the time of diagnoses (three of six 
of the reported cases, and 41% of the reviewed cases). Most (87.5%) 
of the reviewed cases had radiological recovery as seen on follow­up 
MRI. Repeat imaging was not requested in the reported patients
The follow­up of our five patients ranged from a few months to 
many years, with a mean of 28 months. All five of these patients 
recovered from their presentation with PRES, four without any 
neurological deficit. There were no reported recurrent episodes. The 
literature review revealed complete recovery in 87.5% of patients. 
This good recovery suggests that PRES is a transient syndrome with a 
favourable outcome if identified correctly and managed appropriately.
Study limitations
This was a retrospective analysis of medical records spanning a 
17­year period. Selection bias is likely to have been introduced 
because only patients referred to the renal service were included.
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Fig. 2. Baseline diagnoses of paediatric patients with renal posterior reversi­
ble encephalopathy syndrome (N=64). (HUS = haemolytic uraemic syn­
drome; CAKUT = congenital abnormalities of the kidney and urinary tract.)
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Fig. 3. Presenting symptoms of paediatric patients with renal posterior re­
versible encephalopathy syndrome (N=64).
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Fig. 4. Patterns of magnetic resonance imaging changes at diagnosis of poste­
rior reversible encephalopathy syndrome (N=64).
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Recommendations
Based on our experience and a review of the literature: 
• The good prognosis associated with PRES should be considered when 
a decision about intensive care in low­resource settings is made.
• Repeat MRI is probably not indicated in patients who have 
undergone a full neurological recovery.
• The need for maintenance antiepileptic medication should be 
determined.
• The usefulness and availability of electroencephalography should 
be determined in this population.
Conclusions
All the reported cases of PRES presented clinically as hypertensive 
emergencies and radiologically with PRES, and most had a complete 
neurological recovery. These case reports support the hypothesis that 
PRES represents the radiological manifestation of a hypertensive 
emergency, now identified since the advent of MRI technology. 
However, the question why this syndrome does not seem to occur in 
patients with Takayasu’s arteritis and other renovascular hypertensive 
disease, where hypertension is frequently severe, highlights the 
probability that there are as yet unidentified processes that result 
in the condition. The need for maintenance antiepileptic treatment 
remains to be determined.
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